Literature DB >> 11895624

Idiopathic anaphylaxis.

Johannes Ring1, Ulf Darsow.   

Abstract

Anaphylaxis represents the maximal variant of an immediate-type allergic reaction involving the whole organism with manifestations in different organ systems. IgE-mediated mast cell and basophil activation is the major pathomechanism; however, immune complex and pseudo-allergic reactions also may lead to the same symptomatology. The most common elicitors are drugs, additives, occupational substances, animal venoms, aeroallergens, and contact urticariogens but also physical factors (cold, heat, ultraviolet light, exercise). When no eliciting factors can be detected, the term "idiopathic anaphylaxis" is used. The diagnosis of idiopathic anaphylaxis is, therefore, a diagnosis of exclusion and may be made only after careful allergy history taking and diagnosis involving in vitro tests. Possible mechanisms underlying the pathophysiology of idiopathic anaphylaxis include undetected diseases (eg, mastocytosis occulta), concomitant anaphylaxis-enhancing medication (b-blockers), secretion of histamine-releasing factor from T lymphocytes, autoantibodies against IgE or IgE receptors, and angiotensin II deficiency. One of the many differential diagnoses of anaphylaxis may have been overlooked. The treatment of idiopathic anaphylaxis follows the rules of antianaphylactic therapy.

Entities:  

Mesh:

Year:  2002        PMID: 11895624     DOI: 10.1007/s11882-002-0036-8

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  44 in total

Review 1.  Anaphylaxis and anaphylactoid reactions. Classification and pathophysiology.

Authors:  J Ring; H Behrendt
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 8.667

2.  Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings.

Authors:  D Ludolph-Hauser; F Ruëff; C Fries; P Schöpf; B Przybilla
Journal:  Lancet       Date:  2001-02-03       Impact factor: 79.321

Review 3.  Lessons for management of anaphylaxis from a study of fatal reactions.

Authors:  R S Pumphrey
Journal:  Clin Exp Allergy       Date:  2000-08       Impact factor: 5.018

4.  Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse.

Authors:  M M Fisher
Journal:  Anaesth Intensive Care       Date:  1986-02       Impact factor: 1.669

5.  Anaphylaxis. A review of 266 cases.

Authors:  S F Kemp; R F Lockey; B L Wolf; P Lieberman
Journal:  Arch Intern Med       Date:  1995-09-11

6.  Severe anaphylaxis and drug-induced beta-blockade.

Authors:  P J Hannaway; G D Hopper
Journal:  N Engl J Med       Date:  1983-06-23       Impact factor: 91.245

7.  Dextran-induced anaphylactoid reactions in man: role of dextran reactive antibodies.

Authors:  H Hedin; W Richter; J Ring
Journal:  Int Arch Allergy Appl Immunol       Date:  1976

Review 8.  [Anaphylaxis: clinical aspects, etiology and course in 118 patients].

Authors:  C L Rohrer; W J Pichler; A Helbling
Journal:  Schweiz Med Wochenschr       Date:  1998-01-17

9.  Can epinephrine inhalations be substituted for epinephrine injection in children at risk for systemic anaphylaxis?

Authors:  F E Simons; X Gu; L M Johnston; K J Simons
Journal:  Pediatrics       Date:  2000-11       Impact factor: 7.124

10.  Cardiac disorders in penicillin-induced anaphylaxis. Association with intravenous epinephrine therapy.

Authors:  T J Sullivan
Journal:  JAMA       Date:  1982-11-05       Impact factor: 56.272

View more
  6 in total

Review 1.  Pathogenesis, newly recognized etiologies, and management of idiopathic anaphylaxis.

Authors:  James L Kuhlen; Yamini V Virkud
Journal:  Discov Med       Date:  2015-02       Impact factor: 2.970

Review 2.  Understanding the mechanisms of anaphylaxis.

Authors:  Richard D Peavy; Dean D Metcalfe
Journal:  Curr Opin Allergy Clin Immunol       Date:  2008-08

Review 3.  Mechanisms of mast cell signaling in anaphylaxis.

Authors:  Dean D Metcalfe; Richard D Peavy; Alasdair M Gilfillan
Journal:  J Allergy Clin Immunol       Date:  2009-10       Impact factor: 10.793

Review 4.  [Histamine intolerance syndrome. Its significance for ENT medicine].

Authors:  I Böttcher; L Klimek
Journal:  HNO       Date:  2008-08       Impact factor: 1.284

5.  Contribution of classic and alternative effector pathways in peanut-induced anaphylactic responses.

Authors:  Joost J Smit; Karina Willemsen; Ine Hassing; Danielle Fiechter; Gert Storm; Louis van Bloois; Jeanette H W Leusen; Maarten Pennings; Dietmar Zaiss; Raymond H H Pieters
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

Review 6.  Idiopathic Anaphylaxis.

Authors:  Bright I Nwaru; Sangeeta Dhami; Aziz Sheikh
Journal:  Curr Treat Options Allergy       Date:  2017-06-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.